Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-172,193
Closed -$3.55M 26
2022
Q3
$3.55M Hold
172,193
0.44% 43
2022
Q2
$4.77M Hold
172,193
0.48% 38
2022
Q1
$7.53M Hold
172,193
0.5% 38
2021
Q4
$9.51M Sell
172,193
-83,398
-33% -$5.15M 0.52% 43
2021
Q3
$15.8M Buy
255,591
+13,295
+5% +$875K 0.68% 35
2021
Q2
$20.6M Buy
242,296
+83,502
+53% +$7.62M 0.82% 39
2021
Q1
$12.6M Buy
+158,794
New +$10.3M 0.44% 50

Other funds holding AFMD

HealthCor Management's AFMD Position: Q4 2022 in Review

HealthCor Management sold out of Affimed (AFMD) in Q4 2022, closing a stake of 172,193 shares — an estimated $3.55M sold.

HealthCor Management first reported a position in AFMD in Q1 2021 and held it in 7 quarters. The position peaked at $20.6M in Q2 2021. 118 funds tracked by Wall St. Rank hold AFMD as of Q4 2022.

  • HealthCor Management reported no remaining Affimed position as of Q4 2022 after selling out during the quarter.
  • HealthCor Management sold 172,193 Affimed shares in Q4 2022, an estimated $3.55M.
  • HealthCor Management first reported a position in Affimed in Q1 2021 and held it in 7 quarters.
  • HealthCor Management's Affimed position peaked at $20.6M in Q2 2021.
  • 118 funds tracked by Wall St. Rank held Affimed as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.